Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, has announced the launch of PurePep® Sonata®+, a mid-pilot scale peptide synthesizer. The new system is an upgraded version of the Company’s previous model, Sonata® XT, known for its reliability and robustness, to further strengthen the Company’s offering.

Mesa Laboratories, Inc., a diversified supplier of quality control instruments and consumables to highly regulated markets has announced the acquisition of Gyros Protein Technologies Holding AB. GPT is headquartered in Uppsala, Sweden and is a leading provider of Immunoassay and Peptide Synthesis solutions that accelerate the discovery, development and manufacturing of biotherapeutics...

Gyrolab p24 Kit offers high throughput and automated analyses, producing results 24 times faster than ELISA, to accelerate lentivirus bioprocess workflows and reduce time to market. The kit also enables high quality data to be generated from small sample volumes, requiring 10 times less sample compared to ELISA. Additionally, minimal matrix interference reduces the need for dilution....

The new scalable instrument and software platform enables production of even the most challenging sequences at the highest possible crude purity and yield. Scientists using peptides in development of novel therapeutics, biological research, or biomaterials development frequently work on long and difficult sequences, including modified cyclic peptides. These are particularly challenging to synthesize

Incorporates Cygnus Technologies’ gold standard reagents. Ready-to-use immunoassay kit designed to increase productivity. Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today introduced Gyrolab® CHO-HCP E3G Kit for impurity analysis in the CMC (chemistry manufacturing and controls) – bioprocess workflow of biotherapeutics...

Gyros Protein Technologies to develop immunoassay kits for biotherapeutic impurity analysis using Cygnus Technologies’ proprietary reagents. Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, and Cygnus Technologies, the leading assay and services provider for the detection and characterization...

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, has  announced Oxford BioMedica® plc, a leading gene and cell therapy group, has invested in two Gyrolab xPlore™ systems....

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassay platforms and leading provider of peptide synthesizers and reagents, has introduced a new 5 CD model, Gyrolab® xPand, in response to customer requests to provide higher throughput, greater flexibility and faster analysis of large sample numbers....

Fleet to provide support for Gyrolab platform users in developing, transferring and optimizing assays. Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, and Fleet Bioprocessing Ltd. (Fleet), an expert provider of contract immunoassay development services and immunoassay reagent manufacture...

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today it has introduced a new reagent kit for early-stage biotherapeutic toxicokinetic (TK) studies. The new Gyrolab^® Generic TK Kit adds to a growing menu of ready-to-use kits, and allows researchers to more efficiently quantify human therapeutic antibodies (IgG) in automated, nanoliter-scale Gyrolab xP and Gyrolab xPlore™ systems....

Gyros Protein Technologies becomes distributor of iLite cell-based reporter gene assays for drug development

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, has announced it has signed a distribution agreement with Euro Diagnostica, the full service assay solution company....

Developed to supportassay development and validation for detection of anti-drug antibodies

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, has announced it has launched a new version of its anti-drug antibody(ADA)solution for the immunogenicity market....

Kit increases efficiency of residual protein A ligand detection

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced it has launched a new version of its Gyrolab™ Protein A Kit. The new Protein A Kit offers increased efficiency and throughput for quantification of residual Protein A ligands...

Agreement includes exclusive distribution of PurePep Coupling Agents in North America

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced it has signed an exclusive distribution agreement with Luxembourg Bio Technologies for two of its proprietary coupling agents, PyOxim® and K-Oxyma®, and HDMA on a non-exclusive basis...

New kit for early-stage biotherapeutic development, optimized for use in Gyrolab systems

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today it has introduced a new kit for early-stage biotherapeutic pharmacokinetic (PK) studies....

Abacus will distribute Gyrolab™ immunoassay products in Australia and New Zealand

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today that it has appointed Abacus ALS as exclusive distributor of its immunoassay products in Australia and New Zealand....

Gyros Japan KK provides sales, field applications and service for the immunoassay business

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced it has established a dedicated office in Tokyo, Japan and has established Gyros Japan KK....

New software module supports in-solution affinity characterization at nanoliter-scale

Gyros AB, a pioneer in miniaturizing and automating immunoassays at nanoliter-scale, today announced the release of Gyrolab™ Affinity Software Module, which is available on both Gyrolab xP workstation and the recently launched single CD Gyrolab xPlore. The new, intuitive software module enables users to easily set up and run in-solution affinity determinations of up to 14 interacting pairs in parallel in just one hour...

Expanded kit offering strengthens position of Gyrolab automated solution for analysis in bioprocess workflows

Gyros AB, a pioneer in miniaturizing and automating immunoassays at nanoliter-scale, today introduced a series of new kits for analysis in bioprocess workflows. The new kits comprise Gyrolab™ CHO-HCP Kits 2-5 and two Gyrolab Human IgG Titer Kits for rapid quantification of IgG. Combined with the automation and high throughput of Gyrolab systems, GyrolabxP workstation and Gyrolab xPlore™, these kits facilitate increased productivity in...

Nanoliter-scale kit rapidly and easily detects and quantifies host cell proteins from Chinese hamster ovary cells

Gyros AB, a pioneer in miniaturizing and automating immunoassays at nanoliter-scale, today announced the introduction of its Gyrolab™ CHO-HCP Kit 1. The new kit detects and quantifies host cell proteins (HCP) from Chinese hamster ovary (CHO) cells used in bioprocessing of biotherapeutics. HCP are measured throughout the production process, as they may affect the safety and efficacy of the biotherapeutic....

Optimized kit for use with Gyros immunoassay platform

Gyros AB, a leader in utilization of microfluidic technologies to miniaturize and automate immunoassays, today announced the launch of its Gyrolab™ Protein A Kit for use on Gyrolab xP workstation. During purification of biotherapeutics, Protein A can leach from the chromatography support and co-elute with the therapeutic antibody product. The contamination complicates subsequent analysis using immunoassays....

Simple, automated, nanoliter-scale assays requiring as little as 1uL of sample. Ready-to-use kits are fully validated for reliable use in clinical research. Accuracy and precision meet or exceed ELISA performance.

Merck Millipore, the Life Science division of Merck, today announced a partnership with Gyros AB to develop, manufacture and commercialize immunoassay kits for the Gyrolab™ platform. The new, fully validated kits from Merck Millipore will enable clinical researchers and drug developers to generate valuable research data much faster than typical ELISA kits. Traditional ELISAs can consume significant time, sample and reagents. With the fully automated, walk-away system from Gyros, up to 560 data points can be generated in a run...